Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare progression free survival in patients treated
with AZD8931 given in combination with anastrozole versus anastrozole alone. The secondary
objective is to investigate the safety and tolerability of AZD8931 given in combination with
anastrozole.